Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)

Clinical trial NCT00918983 · COMPLETED

Trial details

NCT number: NCT00918983
Sponsor: Nymox Corporation
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Benign Prostatic Hyperplasia

Start date: 2009-04-01
Primary completion: 2013-11-01
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.